Health
Early study suggests Pfizer vaccine effective against coronavirus mutations – Business Insider Australia
The COVID-19 vaccine from pharmaceutical companies Pfizer and BioNTech looks to be effective against 16 different mutations of the coronavirus, according to a study…
- A study by Pfizer and researchers at the University of Texas Medical Branch indicates the company’s COVID-19 vaccine is effective against mutations of the coronavirus.
- The study has not yet been peer-reviewed.
- “So we’ve now tested 16 different mutations, and none of them have really had any significant impact. That’s the good news,” Phil Dormitzer, a scientist at Pfizer, said Thursday.
- “That doesn’t mean that the 17th won’t,” he added.
- Visit Business Insider’s homepage for more stories.
The COVID-19…
Continue Reading
